Skin Lesions for 29 Percent With Anti-TNF Treatment in IBD
All but 11 percent of patients were managed successfully without needing to stop treatment
ASH: Venetoclax, Acalabrutinib Active in Relapsed CLL
Two studies show beneficial effects for patients with relapsed chronic lymphocytic leukemia
ASH: Prasugrel Doesn’t Cut Vaso-Occlusive Crisis in Sickle Cell
Rate of vaso-occlusive crisis events is not lower for children receiving prasugrel versus placebo
ADT for Prostate CA Tied to Increased Alzheimer’s Risk
Research suggests dose-dependent effect
Cannabidiol Shows Promise in Pediatric Epilepsy
Preliminary studies link cannabidiol to seizure reduction, but drug interactions remain a concern
CDC: Fewer Americans Struggling With Medical Bills
U.S. report shows 12 million are no longer in families having trouble paying for health care
FDA Approves Kanuma for Lysosomal Acid Lipase Deficiency
For treatment of LAL deficiency, also known as Wolman disease or cholesteryl ester storage disease
FDA Approves Vonvendi to Treat von Willebrand Disease
Approved for the as-needed treatment and control of bleeding episodes in adults
Statin Treatment Linked to Reduced Risk of Cataracts
Simvastatin plus ezetimibe linked to lower risk of cataract development versus placebo
Variation in Prices of Cancer Drugs in High-Income Countries
Difference in drug price between highest-, lowest-priced countries varies between 28 and 388 percent
